Related references
Note: Only part of the references are listed.The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters
Rana Abdelnabi et al.
ANTIVIRAL RESEARCH (2022)
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
Wilfredo F. Garcia-Beltran et al.
CELL (2022)
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review
Simon Galmiche et al.
CLINICAL MICROBIOLOGY AND INFECTION (2022)
Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves
Caroline Maslo et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum
Wanwisa Dejnirattisai et al.
LANCET (2022)
Real-world Effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S Vaccines Against SARS-CoV-2 in Solid Organ and Islet Transplant Recipients
Chris J. Callaghan et al.
TRANSPLANTATION (2022)
Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients A Randomized Clinical Trial
Roman Reindl-Schwaighofer et al.
JAMA INTERNAL MEDICINE (2022)
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance — One Hospital, California, July 15–September 23, 2021, and December 21, 2021–January 27, 2022
Matthew E Modes et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)
Neutralization against Omicron variant in transplant recipients after three doses of mRNA vaccine
Deepali Kumar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2022)
Resistance Mutations in SARS-CoV-2 Delta Variant after Sotrovimab Use
Rebecca Rockett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Evaluating the antibody response to SARS-COV-2 vaccination amongst kidney transplant recipients at a single nephrology centre
Chukwuma A. Chukwu et al.
PLOS ONE (2022)
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
Adam S. Lauring et al.
BMJ-BRITISH MEDICAL JOURNAL (2022)
Cell-based Culture Informs Infectivity and Safe De-Isolation Assessments in Patients with Coronavirus Disease 2019
Kerri Basile et al.
CLINICAL INFECTIOUS DISEASES (2021)
Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
Salim S. Abdool Karim et al.
LANCET (2021)
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab
Anil Gupta et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
Brian J. Boyarsky et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Incidence and Outcomes of COVID-19 in People With CKD: A Systematic Review and Meta-analysis
Edmund Y. M. Chung et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2021)
SARS-CoV-2 Genome Sequencing Methods Differ in Their Abilities To Detect Variants from Low-Viral-Load Samples
C. Lam et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2021)
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
Nassim Kamar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients
Saima Aslam et al.
TRANSPLANT INFECTIOUS DISEASE (2021)
Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool
Aine O'Toole et al.
VIRUS EVOLUTION (2021)
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology
Andrew Rambaut et al.
NATURE MICROBIOLOGY (2020)
Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling
Rebecca J. Rockett et al.
NATURE MEDICINE (2020)